Moneycontrol
HomeNewsIndiaRailways operated 1,414 'Shramik Special' trains, 496 from Gujarat, 266 from Maharashtra so far

Railways operated 1,414 'Shramik Special' trains, 496 from Gujarat, 266 from Maharashtra so far

Out of the trains, which have terminated so far, the maximum has been in Uttar Pradesh (641) while 73 more are in transit, followed by Bihar (310) with 53 more on its way to the state.

May 18, 2020 / 21:59 IST
Story continues below Advertisement
Representative image (Image: AP)

The Indian Railways has operated 1,414 'Shramik Special' trains so far since May 1 and most of them have originated from Gujarat and Maharashtra, the national transporter has said. While 162 trains are in transit, 1,252 trains have reached their destinations. Around 116 trains are currently in the pipeline, it said.

Since May 1, the railways has ferried around 18.5 lakh migrants home.

Story continues below Advertisement

According to available data, 496 trains have originated from Gujarat and 17 more are in the pipeline, while 266 trains have already started from Maharashtra, with 37 more in the pipeline.

Among the other originating states, 188 trains have started from Punjab, 89 from Karnataka, 61 from Tamil Nadu, 58 from Telangana, 54 from Rajasthan, 41 from Haryana and 38 from Uttar Pradesh.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show